Microsaic Systems (MSYS), the developer of point of need mass spectrometry instruments, provided an unaudited trading update for the year ended 31 December 2021. It confirmed that revenues for FY21 have significantly exceeded those of FY20, recovering to a level slightly ahead of that in FY19, a pre-pandemic benchmark.
By Zak Mir
Thor Explorations (THX) provided an operational update and outlook for the full year of 2022. Things appear to have changed in a positive way as the company said that supply chain issues have been resolved, the laboratory has been fully commissioned and gold shipments have been made successfully, and the Segilola process plant is now running continuously at design capacity with 61,128t of ore processed during the month of December with a head grade of 3.4 grammes per tonne.
Hydrogen Utopia International (HUI), a company pioneering non-recyclable waste plastics to hydrogen technology, and whose shares have soared on Aquis since the IPO last week – all the more of an achievement since are on Aquis, announced that its wholly-owned Polish subsidiary, Hydropolis United sp z.o.o., has signed a letter of intent with RZZO sp z.o.o., the regional municipal waste management company operating in Ostrów Wielkopolski, Greater Poland. The LOI was signed in the presence of and with the full support of the Mayor of Ostrów Wielkopolski, Beata Klimek, and the Deputy Mayor, Mikołaj Kostka.
Powerhouse Energy Group (PHE), the UK technology company commercialising hydrogen production from waste plastic, said it was pleased to note that its development partner, Hydrogen Utopia International, has had its ordinary shares admitted to trading on the AQSE Growth Market on 6 January 2022. Presumably the powers that be at PHE have been partying over the past four days and have only just realised that their licensee has been floated and the shares doubled in 24 hours. It may be that some PHE shareholders start to nibble at HUI, given that they have now been officially alerted to what is going on in the world.
Genflow Biosciences, a UK-based biotechnology company focused on longevity and the development of therapies to counteract the effects of aging and diseases associated with advanced age, said it is seeking a listing on the Standard Listing segment of the London Stock Exchange. The company will become the first longevity biotechnology firm to list in Europe. Genflow has raised £3.7m in an oversubscribed placing, conditional upon admission becoming effective. The flotation will value Genflow at approximately £23.4m. Net proceeds from the IPO will be deployed to further research into the impact of the Sirtuin-6 gene mutation on the ageing process and its potential beneficial impact on health spans. The company also got a mention in The Telegraph to this effect today.
ECR Minerals (ECR), the gold exploration and development company focussed on gold exploration in Australia, announced that it has submitted an application to renew current exploration license EL006184 for an extended five-year term. EL006184 covers land owned by one of ECR Minerals plc 100% owned Creswick projects and is operated by its subsidiary company Mercator Gold Australia Pty Ltd.
Abingdon Health (ABDX), a developer and manufacturer of rapid tests, updated on Avacta Group (AVCT) AffiDX® SARS-CoV-2 antigen lateral flow test. The company notes that Avacta’s Affimer® reagent in the AffiDX® test detects the Omicron variant with the same sensitivity as the Delta variant, and that it is the performance of the antibody, which pairs with the Affimer® in the test, that has been affected by the additional Omicron mutations. Abingdon scientists will work with Avacta to accelerate the process of replacing the antibody in the current assay format, and complete the process of technology transfer with this new specification.
NetScientific (NSCI), the international life sciences and sustainability technology investment group, announced that its wholly owned subsidiary ProAxsis Limited, has provided a CEO update on the progress it made during 2021. NSCI said it was “delighted with the continued progress being made at ProAxsis with accelerated developments, new products and additional revenue streams in 2022.”
ANGLE (AGL), a liquid biopsy company, said that a team led by Prof. Evi Lianidou at the National and Kapodistrian University of Athens (Greece), has published results of a further study undertaken in non-small cell lung cancer patients with an EGFR mutation being treated with the tyrosine kinase inhibitor, Osimertinib (AstraZeneca’s Tagrisso®), which demonstrates the benefit of longitudinal analysis of epigenetic alterations in circulating tumour cells. Angle said the study further demonstrates the dynamic nature of NSCLC and the need for analysis of CTCs and not just ctDNA from serial liquid biopsies to provide information on disease progression and drug resistance.
KEFI (KEFI), the gold exploration and development company, provided its latest quarterly operational update. The company said during the fourth quarter of 2021, security events in Ethiopia stalled our progress at Tulu Kapi, but it preserved the finance syndicate and its preparations for the project launch when security and other normal conditions are satisfied as early as possible in 2022. In Saudi Arabia it noted the expansion of the Hawiah Copper-Gold Project Mineral Resource, the Jibal Qutman Gold Project now targets a Mining Licence during 2022 and it has been granted the Al Godeyer Exploration Licences 11 kms from Hawiah, covering a geological analogue of the main deposit.
Dekel Agri-Vision (DKL), the West African focused agriculture company, provided a production update for its 100%-owned vertically integrated Ayenouan palm oil project in Côte d’Ivoire for the year ended 31 December 2021. The company said that with CPO prices continuing to remain at 10-year highs, it is looking forward to the upcoming high season. Together with the commencement of production at its cashew project at Tiebissou, the year ahead will see a further material uplift from 2021’s strong performance.
Audioboom (BOOM), the global podcast company, provided a trading update for the 12 months ended 31 December 2021. The company said 2021 was a phenomenal year for Audioboom and achieving profitability on both an adjusted EBITDA and net basis is transformative, establishing a self-sustaining business funded for continued growth, and reshaping shareholder value. Recent weeks have seen speculators try and pin the most likely bidder for the group on the company from the tech space, to see which one fits. Ironically, almost all of them do.
Canadian Overseas Petroleum (COPL), an international oil and gas exploration company with operations focused in Wyoming, USA, announced a significant conventional light oil discovery at its Wyoming asset. In addition, COPL provides an operational update on its Barron Flats Shannon Field production. The company said it acquired Atomic Oil & Gas in January 2021 aware of the significant exploration upside. Since then, it has increased production from the existing wells and accelerated our exploration program which has resulted in today’s announced discovery. This highlights the potential for the Wyoming asset to generate long-term production on a scale many multiples greater than its original expectation. It will be interesting to see whether the latest announcement from COPL is enough to get the stock to trade higher than it was before its transformational dealmaking and production prospects were envisaged a year ago? Or then the pesky seller is finally out…
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
